Addus HomeCare’s (ADUS) Outperform Rating Reiterated at Royal Bank of Canada

Royal Bank of Canada reiterated their outperform rating on shares of Addus HomeCare (NASDAQ:ADUS) in a report released on Thursday morning,Benzinga reports. The brokerage currently has a $136.00 target price on the stock.

ADUS has been the subject of a number of other research reports. Stephens raised their target price on shares of Addus HomeCare from $143.00 to $145.00 and gave the company an “overweight” rating in a research note on Wednesday, November 6th. Oppenheimer lifted their price objective on Addus HomeCare from $140.00 to $145.00 and gave the company an “outperform” rating in a research note on Monday, September 23rd. Macquarie restated an “outperform” rating and set a $139.00 price target on shares of Addus HomeCare in a report on Monday, November 4th. KeyCorp assumed coverage on Addus HomeCare in a research report on Friday, October 11th. They issued an “overweight” rating and a $150.00 price target for the company. Finally, TD Cowen increased their price objective on shares of Addus HomeCare from $128.00 to $137.00 and gave the company a “buy” rating in a research report on Thursday, August 8th. One research analyst has rated the stock with a sell rating, eight have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $131.63.

Addus HomeCare Trading Down 1.9 %

ADUS stock opened at $119.78 on Thursday. The stock has a market capitalization of $2.17 billion, a price-to-earnings ratio of 27.41, a PEG ratio of 2.09 and a beta of 1.04. The firm’s 50-day moving average price is $128.99 and its two-hundred day moving average price is $122.59. Addus HomeCare has a 12-month low of $85.43 and a 12-month high of $136.12.

Addus HomeCare (NASDAQ:ADUS) last issued its quarterly earnings data on Monday, November 4th. The company reported $1.30 EPS for the quarter, topping the consensus estimate of $1.28 by $0.02. Addus HomeCare had a net margin of 6.50% and a return on equity of 9.62%. The business had revenue of $289.80 million during the quarter, compared to analyst estimates of $289.42 million. During the same period in the prior year, the business earned $1.03 EPS. The company’s revenue for the quarter was up 7.1% on a year-over-year basis. Equities analysts predict that Addus HomeCare will post 4.58 EPS for the current year.

Insider Transactions at Addus HomeCare

In other Addus HomeCare news, EVP Michael D. Wattenbarger sold 21,917 shares of the business’s stock in a transaction dated Monday, August 26th. The stock was sold at an average price of $133.29, for a total transaction of $2,921,316.93. Following the completion of the sale, the executive vice president now directly owns 7,215 shares in the company, valued at $961,687.35. The trade was a 75.23 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, Director Esteban Lopez sold 500 shares of the company’s stock in a transaction dated Wednesday, September 4th. The shares were sold at an average price of $130.03, for a total transaction of $65,015.00. Following the sale, the director now directly owns 3,866 shares of the company’s stock, valued at $502,695.98. The trade was a 11.45 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 22,917 shares of company stock worth $3,050,082 over the last three months. 4.60% of the stock is currently owned by company insiders.

Institutional Trading of Addus HomeCare

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Point72 Asset Management L.P. boosted its stake in shares of Addus HomeCare by 73.4% during the 2nd quarter. Point72 Asset Management L.P. now owns 745,824 shares of the company’s stock worth $86,598,000 after acquiring an additional 315,602 shares during the last quarter. Millennium Management LLC lifted its position in Addus HomeCare by 412.7% during the second quarter. Millennium Management LLC now owns 316,418 shares of the company’s stock valued at $36,739,000 after purchasing an additional 254,705 shares in the last quarter. Boston Partners bought a new stake in Addus HomeCare during the first quarter valued at about $12,215,000. Wasatch Advisors LP increased its position in Addus HomeCare by 11.8% in the third quarter. Wasatch Advisors LP now owns 1,043,240 shares of the company’s stock worth $138,782,000 after buying an additional 110,010 shares in the last quarter. Finally, Ghisallo Capital Management LLC bought a new position in shares of Addus HomeCare in the second quarter worth about $11,611,000. 95.35% of the stock is owned by hedge funds and other institutional investors.

Addus HomeCare Company Profile

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.